nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—Fluorouracil—head and neck cancer	0.185	0.284	CbGbCtD
Pantoprazole—ABCG2—Docetaxel—head and neck cancer	0.141	0.217	CbGbCtD
Pantoprazole—CYP1A2—Fluorouracil—head and neck cancer	0.0763	0.117	CbGbCtD
Pantoprazole—CYP2C9—Fluorouracil—head and neck cancer	0.0687	0.105	CbGbCtD
Pantoprazole—ABCB1—Vinblastine—head and neck cancer	0.0618	0.0948	CbGbCtD
Pantoprazole—ABCB1—Docetaxel—head and neck cancer	0.0509	0.0782	CbGbCtD
Pantoprazole—CYP3A4—Vinblastine—head and neck cancer	0.037	0.0568	CbGbCtD
Pantoprazole—CYP3A4—Docetaxel—head and neck cancer	0.0305	0.0468	CbGbCtD
Pantoprazole—ATP4B—Ion transport by P-type ATPases—ATP7B—head and neck cancer	0.00837	0.118	CbGpPWpGaD
Pantoprazole—ATP4A—Ion transport by P-type ATPases—ATP7B—head and neck cancer	0.00746	0.105	CbGpPWpGaD
Pantoprazole—Rabeprazole—CYP1A1—head and neck cancer	0.00407	0.391	CrCbGaD
Pantoprazole—Omeprazole—CYP1A1—head and neck cancer	0.00332	0.318	CrCbGaD
Pantoprazole—Lansoprazole—CYP1A1—head and neck cancer	0.00304	0.291	CrCbGaD
Pantoprazole—ATP4B—Ion channel transport—ATP7B—head and neck cancer	0.0029	0.0407	CbGpPWpGaD
Pantoprazole—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00287	0.0404	CbGpPWpGaD
Pantoprazole—ATP4A—Ion channel transport—ATP7B—head and neck cancer	0.00258	0.0363	CbGpPWpGaD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00224	0.0315	CbGpPWpGaD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00149	0.021	CbGpPWpGaD
Pantoprazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00137	0.0193	CbGpPWpGaD
Pantoprazole—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00125	0.0176	CbGpPWpGaD
Pantoprazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00125	0.0176	CbGpPWpGaD
Pantoprazole—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00125	0.0175	CbGpPWpGaD
Pantoprazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00114	0.016	CbGpPWpGaD
Pantoprazole—Blood pressure increased—Docetaxel—head and neck cancer	0.00109	0.00409	CcSEcCtD
Pantoprazole—Hepatocellular injury—Docetaxel—head and neck cancer	0.00109	0.00409	CcSEcCtD
Pantoprazole—Injection site reaction—Docetaxel—head and neck cancer	0.00109	0.00407	CcSEcCtD
Pantoprazole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00107	0.015	CbGpPWpGaD
Pantoprazole—Haemoglobin—Hydroxyurea—head and neck cancer	0.00106	0.00398	CcSEcCtD
Pantoprazole—Influenza like illness—Docetaxel—head and neck cancer	0.00106	0.00398	CcSEcCtD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00106	0.0149	CbGpPWpGaD
Pantoprazole—Haemorrhage—Hydroxyurea—head and neck cancer	0.00106	0.00396	CcSEcCtD
Pantoprazole—Hallucination—Hydroxyurea—head and neck cancer	0.00105	0.00394	CcSEcCtD
Pantoprazole—Colitis—Docetaxel—head and neck cancer	0.00105	0.00393	CcSEcCtD
Pantoprazole—Candida infection—Docetaxel—head and neck cancer	0.00104	0.00391	CcSEcCtD
Pantoprazole—Fluid retention—Docetaxel—head and neck cancer	0.00104	0.00389	CcSEcCtD
Pantoprazole—Neuropathy—Docetaxel—head and neck cancer	0.00103	0.00384	CcSEcCtD
Pantoprazole—Alopecia—Vinblastine—head and neck cancer	0.00102	0.00383	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00101	0.0142	CbGpPWpGaD
Pantoprazole—Dry skin—Fluorouracil—head and neck cancer	0.00101	0.00377	CcSEcCtD
Pantoprazole—Oesophagitis—Docetaxel—head and neck cancer	0.000999	0.00374	CcSEcCtD
Pantoprazole—Neoplasm—Docetaxel—head and neck cancer	0.000989	0.0037	CcSEcCtD
Pantoprazole—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000984	0.00368	CcSEcCtD
Pantoprazole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000972	0.0137	CbGpPWpGaD
Pantoprazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000968	0.0136	CbGpPWpGaD
Pantoprazole—Dysphagia—Fluorouracil—head and neck cancer	0.000951	0.00356	CcSEcCtD
Pantoprazole—Sepsis—Docetaxel—head and neck cancer	0.000949	0.00355	CcSEcCtD
Pantoprazole—Chills—Hydroxyurea—head and neck cancer	0.000948	0.00355	CcSEcCtD
Pantoprazole—Eosinophilia—Fluorouracil—head and neck cancer	0.000941	0.00352	CcSEcCtD
Pantoprazole—Ill-defined disorder—Vinblastine—head and neck cancer	0.000936	0.00351	CcSEcCtD
Pantoprazole—Alopecia—Hydroxyurea—head and neck cancer	0.000934	0.0035	CcSEcCtD
Pantoprazole—Anaemia—Vinblastine—head and neck cancer	0.000933	0.00349	CcSEcCtD
Pantoprazole—Angina pectoris—Fluorouracil—head and neck cancer	0.000926	0.00347	CcSEcCtD
Pantoprazole—Thrombophlebitis—Docetaxel—head and neck cancer	0.000917	0.00343	CcSEcCtD
Pantoprazole—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000913	0.00342	CcSEcCtD
Pantoprazole—Malaise—Vinblastine—head and neck cancer	0.00091	0.00341	CcSEcCtD
Pantoprazole—Vertigo—Vinblastine—head and neck cancer	0.000907	0.00339	CcSEcCtD
Pantoprazole—Leukopenia—Vinblastine—head and neck cancer	0.000903	0.00338	CcSEcCtD
Pantoprazole—Pancytopenia—Fluorouracil—head and neck cancer	0.000903	0.00338	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000899	0.0126	CbGpPWpGaD
Pantoprazole—Deafness—Docetaxel—head and neck cancer	0.000887	0.00332	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000883	0.00331	CcSEcCtD
Pantoprazole—Hepatic failure—Docetaxel—head and neck cancer	0.000883	0.00331	CcSEcCtD
Pantoprazole—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000875	0.00328	CcSEcCtD
Pantoprazole—Convulsion—Vinblastine—head and neck cancer	0.000874	0.00327	CcSEcCtD
Pantoprazole—Hypertension—Vinblastine—head and neck cancer	0.000871	0.00326	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000868	0.00325	CcSEcCtD
Pantoprazole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000854	0.0032	CcSEcCtD
Pantoprazole—Pneumonia—Fluorouracil—head and neck cancer	0.000852	0.00319	CcSEcCtD
Pantoprazole—Anaemia—Hydroxyurea—head and neck cancer	0.000851	0.00318	CcSEcCtD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00085	0.0119	CbGpPWpGaD
Pantoprazole—Discomfort—Vinblastine—head and neck cancer	0.000849	0.00318	CcSEcCtD
Pantoprazole—Hot flush—Docetaxel—head and neck cancer	0.000849	0.00318	CcSEcCtD
Pantoprazole—Infestation NOS—Fluorouracil—head and neck cancer	0.000848	0.00317	CcSEcCtD
Pantoprazole—Infestation—Fluorouracil—head and neck cancer	0.000848	0.00317	CcSEcCtD
Pantoprazole—Menopausal symptoms—Docetaxel—head and neck cancer	0.000841	0.00315	CcSEcCtD
Pantoprazole—Visual disturbance—Docetaxel—head and neck cancer	0.000838	0.00314	CcSEcCtD
Pantoprazole—Atrial fibrillation—Docetaxel—head and neck cancer	0.000838	0.00314	CcSEcCtD
Pantoprazole—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000836	0.00313	CcSEcCtD
Pantoprazole—Myocardial infarction—Fluorouracil—head and neck cancer	0.000831	0.00311	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000831	0.00311	CcSEcCtD
Pantoprazole—Malaise—Hydroxyurea—head and neck cancer	0.00083	0.00311	CcSEcCtD
Pantoprazole—Stomatitis—Fluorouracil—head and neck cancer	0.000826	0.00309	CcSEcCtD
Pantoprazole—Urinary tract infection—Fluorouracil—head and neck cancer	0.000824	0.00308	CcSEcCtD
Pantoprazole—Conjunctivitis—Fluorouracil—head and neck cancer	0.000824	0.00308	CcSEcCtD
Pantoprazole—Leukopenia—Hydroxyurea—head and neck cancer	0.000824	0.00308	CcSEcCtD
Pantoprazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000821	0.0115	CbGpPWpGaD
Pantoprazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.000806	0.00302	CcSEcCtD
Pantoprazole—Epistaxis—Fluorouracil—head and neck cancer	0.000799	0.00299	CcSEcCtD
Pantoprazole—Convulsion—Hydroxyurea—head and neck cancer	0.000797	0.00299	CcSEcCtD
Pantoprazole—Hyponatraemia—Docetaxel—head and neck cancer	0.000797	0.00298	CcSEcCtD
Pantoprazole—Sinusitis—Fluorouracil—head and neck cancer	0.000795	0.00298	CcSEcCtD
Pantoprazole—Pain in extremity—Docetaxel—head and neck cancer	0.000794	0.00297	CcSEcCtD
Pantoprazole—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000794	0.00297	CcSEcCtD
Pantoprazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.000791	0.00296	CcSEcCtD
Pantoprazole—Anorexia—Vinblastine—head and neck cancer	0.000785	0.00294	CcSEcCtD
Pantoprazole—Migraine—Docetaxel—head and neck cancer	0.000781	0.00293	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000778	0.00291	CcSEcCtD
Pantoprazole—Discomfort—Hydroxyurea—head and neck cancer	0.000774	0.0029	CcSEcCtD
Pantoprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000767	0.0108	CbGpPWpGaD
Pantoprazole—Haemoglobin—Fluorouracil—head and neck cancer	0.000765	0.00286	CcSEcCtD
Pantoprazole—Rhinitis—Fluorouracil—head and neck cancer	0.000763	0.00286	CcSEcCtD
Pantoprazole—Haemorrhage—Fluorouracil—head and neck cancer	0.000761	0.00285	CcSEcCtD
Pantoprazole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000757	0.00283	CcSEcCtD
Pantoprazole—Pharyngitis—Fluorouracil—head and neck cancer	0.000755	0.00283	CcSEcCtD
Pantoprazole—Oedema—Hydroxyurea—head and neck cancer	0.000751	0.00281	CcSEcCtD
Pantoprazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00075	0.0105	CbGpPWpGaD
Pantoprazole—Infection—Hydroxyurea—head and neck cancer	0.000746	0.00279	CcSEcCtD
Pantoprazole—Paraesthesia—Vinblastine—head and neck cancer	0.000739	0.00277	CcSEcCtD
Pantoprazole—Dehydration—Docetaxel—head and neck cancer	0.000738	0.00276	CcSEcCtD
Pantoprazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000736	0.00276	CcSEcCtD
Pantoprazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000735	0.00275	CcSEcCtD
Pantoprazole—Liver function test abnormal—Docetaxel—head and neck cancer	0.000733	0.00274	CcSEcCtD
Pantoprazole—Skin disorder—Hydroxyurea—head and neck cancer	0.000729	0.00273	CcSEcCtD
Pantoprazole—Dry skin—Docetaxel—head and neck cancer	0.000728	0.00272	CcSEcCtD
Pantoprazole—Abdominal pain upper—Docetaxel—head and neck cancer	0.000725	0.00271	CcSEcCtD
Pantoprazole—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000724	0.0102	CbGpPWpGaD
Pantoprazole—Breast disorder—Docetaxel—head and neck cancer	0.000717	0.00269	CcSEcCtD
Pantoprazole—Anorexia—Hydroxyurea—head and neck cancer	0.000716	0.00268	CcSEcCtD
Pantoprazole—Decreased appetite—Vinblastine—head and neck cancer	0.000716	0.00268	CcSEcCtD
Pantoprazole—Cramp muscle—Docetaxel—head and neck cancer	0.000715	0.00268	CcSEcCtD
Pantoprazole—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000715	0.00268	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000715	0.00268	CcSEcCtD
Pantoprazole—Nasopharyngitis—Docetaxel—head and neck cancer	0.00071	0.00266	CcSEcCtD
Pantoprazole—Pain—Vinblastine—head and neck cancer	0.000704	0.00264	CcSEcCtD
Pantoprazole—Constipation—Vinblastine—head and neck cancer	0.000704	0.00264	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.0007	0.00262	CcSEcCtD
Pantoprazole—Dysphagia—Docetaxel—head and neck cancer	0.000686	0.00257	CcSEcCtD
Pantoprazole—Arrhythmia—Fluorouracil—head and neck cancer	0.00068	0.00254	CcSEcCtD
Pantoprazole—Feeling abnormal—Vinblastine—head and neck cancer	0.000679	0.00254	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000673	0.00252	CcSEcCtD
Pantoprazole—Alopecia—Fluorouracil—head and neck cancer	0.000672	0.00252	CcSEcCtD
Pantoprazole—Dyspnoea—Hydroxyurea—head and neck cancer	0.00067	0.00251	CcSEcCtD
Pantoprazole—Angina pectoris—Docetaxel—head and neck cancer	0.000668	0.0025	CcSEcCtD
Pantoprazole—Somnolence—Hydroxyurea—head and neck cancer	0.000668	0.0025	CcSEcCtD
Pantoprazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.000661	0.00248	CcSEcCtD
Pantoprazole—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000659	0.00925	CbGpPWpGaD
Pantoprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000656	0.00921	CbGpPWpGaD
Pantoprazole—Decreased appetite—Hydroxyurea—head and neck cancer	0.000653	0.00244	CcSEcCtD
Pantoprazole—Pancytopenia—Docetaxel—head and neck cancer	0.000652	0.00244	CcSEcCtD
Pantoprazole—Abdominal pain—Vinblastine—head and neck cancer	0.000651	0.00244	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000648	0.00243	CcSEcCtD
Pantoprazole—Fatigue—Hydroxyurea—head and neck cancer	0.000647	0.00242	CcSEcCtD
Pantoprazole—Constipation—Hydroxyurea—head and neck cancer	0.000642	0.0024	CcSEcCtD
Pantoprazole—Pain—Hydroxyurea—head and neck cancer	0.000642	0.0024	CcSEcCtD
Pantoprazole—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000633	0.0089	CbGpPWpGaD
Pantoprazole—Weight increased—Docetaxel—head and neck cancer	0.000624	0.00234	CcSEcCtD
Pantoprazole—Vision blurred—Fluorouracil—head and neck cancer	0.000624	0.00234	CcSEcCtD
Pantoprazole—Weight decreased—Docetaxel—head and neck cancer	0.000621	0.00232	CcSEcCtD
Pantoprazole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000619	0.00232	CcSEcCtD
Pantoprazole—Pneumonia—Docetaxel—head and neck cancer	0.000615	0.0023	CcSEcCtD
Pantoprazole—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000613	0.00862	CbGpPWpGaD
Pantoprazole—Anaemia—Fluorouracil—head and neck cancer	0.000612	0.00229	CcSEcCtD
Pantoprazole—Infestation NOS—Docetaxel—head and neck cancer	0.000612	0.00229	CcSEcCtD
Pantoprazole—Infestation—Docetaxel—head and neck cancer	0.000612	0.00229	CcSEcCtD
Pantoprazole—Hypersensitivity—Vinblastine—head and neck cancer	0.000607	0.00227	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000606	0.00227	CcSEcCtD
Pantoprazole—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000603	0.00226	CcSEcCtD
Pantoprazole—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000601	0.00844	CbGpPWpGaD
Pantoprazole—Myocardial infarction—Docetaxel—head and neck cancer	0.0006	0.00225	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0006	0.00225	CcSEcCtD
Pantoprazole—Jaundice—Docetaxel—head and neck cancer	0.000596	0.00223	CcSEcCtD
Pantoprazole—Stomatitis—Docetaxel—head and neck cancer	0.000596	0.00223	CcSEcCtD
Pantoprazole—Conjunctivitis—Docetaxel—head and neck cancer	0.000595	0.00223	CcSEcCtD
Pantoprazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000594	0.00222	CcSEcCtD
Pantoprazole—Leukopenia—Fluorouracil—head and neck cancer	0.000593	0.00222	CcSEcCtD
Pantoprazole—Asthenia—Vinblastine—head and neck cancer	0.000591	0.00221	CcSEcCtD
Pantoprazole—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000589	0.00828	CbGpPWpGaD
Pantoprazole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000579	0.00217	CcSEcCtD
Pantoprazole—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000578	0.00812	CbGpPWpGaD
Pantoprazole—Epistaxis—Docetaxel—head and neck cancer	0.000577	0.00216	CcSEcCtD
Pantoprazole—Convulsion—Fluorouracil—head and neck cancer	0.000574	0.00215	CcSEcCtD
Pantoprazole—Agranulocytosis—Docetaxel—head and neck cancer	0.000571	0.00214	CcSEcCtD
Pantoprazole—Myalgia—Fluorouracil—head and neck cancer	0.000564	0.00211	CcSEcCtD
Pantoprazole—Chest pain—Fluorouracil—head and neck cancer	0.000564	0.00211	CcSEcCtD
Pantoprazole—Diarrhoea—Vinblastine—head and neck cancer	0.000563	0.00211	CcSEcCtD
Pantoprazole—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000558	0.00785	CbGpPWpGaD
Pantoprazole—Discomfort—Fluorouracil—head and neck cancer	0.000557	0.00209	CcSEcCtD
Pantoprazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000553	0.00207	CcSEcCtD
Pantoprazole—Haemoglobin—Docetaxel—head and neck cancer	0.000552	0.00207	CcSEcCtD
Pantoprazole—Rhinitis—Docetaxel—head and neck cancer	0.000551	0.00206	CcSEcCtD
Pantoprazole—Hepatitis—Docetaxel—head and neck cancer	0.000549	0.00206	CcSEcCtD
Pantoprazole—Haemorrhage—Docetaxel—head and neck cancer	0.000549	0.00206	CcSEcCtD
Pantoprazole—Hypoaesthesia—Docetaxel—head and neck cancer	0.000546	0.00205	CcSEcCtD
Pantoprazole—Confusional state—Fluorouracil—head and neck cancer	0.000545	0.00204	CcSEcCtD
Pantoprazole—Pharyngitis—Docetaxel—head and neck cancer	0.000545	0.00204	CcSEcCtD
Pantoprazole—Dizziness—Vinblastine—head and neck cancer	0.000545	0.00204	CcSEcCtD
Pantoprazole—Urinary tract disorder—Docetaxel—head and neck cancer	0.000542	0.00203	CcSEcCtD
Pantoprazole—Oedema peripheral—Docetaxel—head and neck cancer	0.000541	0.00203	CcSEcCtD
Pantoprazole—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000541	0.00202	CcSEcCtD
Pantoprazole—Oedema—Fluorouracil—head and neck cancer	0.000541	0.00202	CcSEcCtD
Pantoprazole—Connective tissue disorder—Docetaxel—head and neck cancer	0.00054	0.00202	CcSEcCtD
Pantoprazole—Asthenia—Hydroxyurea—head and neck cancer	0.000539	0.00202	CcSEcCtD
Pantoprazole—Urethral disorder—Docetaxel—head and neck cancer	0.000538	0.00202	CcSEcCtD
Pantoprazole—Infection—Fluorouracil—head and neck cancer	0.000537	0.00201	CcSEcCtD
Pantoprazole—Nervous system disorder—Fluorouracil—head and neck cancer	0.00053	0.00198	CcSEcCtD
Pantoprazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000529	0.00198	CcSEcCtD
Pantoprazole—Visual impairment—Docetaxel—head and neck cancer	0.000529	0.00198	CcSEcCtD
Pantoprazole—Tachycardia—Fluorouracil—head and neck cancer	0.000528	0.00198	CcSEcCtD
Pantoprazole—Vomiting—Vinblastine—head and neck cancer	0.000524	0.00196	CcSEcCtD
Pantoprazole—Erythema multiforme—Docetaxel—head and neck cancer	0.000519	0.00194	CcSEcCtD
Pantoprazole—Headache—Vinblastine—head and neck cancer	0.000516	0.00193	CcSEcCtD
Pantoprazole—Anorexia—Fluorouracil—head and neck cancer	0.000515	0.00193	CcSEcCtD
Pantoprazole—Diarrhoea—Hydroxyurea—head and neck cancer	0.000514	0.00192	CcSEcCtD
Pantoprazole—Eye disorder—Docetaxel—head and neck cancer	0.000513	0.00192	CcSEcCtD
Pantoprazole—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000513	0.00721	CbGpPWpGaD
Pantoprazole—Flushing—Docetaxel—head and neck cancer	0.00051	0.00191	CcSEcCtD
Pantoprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000506	0.00711	CbGpPWpGaD
Pantoprazole—Hypotension—Fluorouracil—head and neck cancer	0.000505	0.00189	CcSEcCtD
Pantoprazole—Dizziness—Hydroxyurea—head and neck cancer	0.000497	0.00186	CcSEcCtD
Pantoprazole—Immune system disorder—Docetaxel—head and neck cancer	0.000496	0.00186	CcSEcCtD
Pantoprazole—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000494	0.00694	CbGpPWpGaD
Pantoprazole—Chills—Docetaxel—head and neck cancer	0.000493	0.00184	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000492	0.00184	CcSEcCtD
Pantoprazole—Arrhythmia—Docetaxel—head and neck cancer	0.000491	0.00184	CcSEcCtD
Pantoprazole—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000489	0.00688	CbGpPWpGaD
Pantoprazole—Nausea—Vinblastine—head and neck cancer	0.000489	0.00183	CcSEcCtD
Pantoprazole—Insomnia—Fluorouracil—head and neck cancer	0.000489	0.00183	CcSEcCtD
Pantoprazole—Paraesthesia—Fluorouracil—head and neck cancer	0.000485	0.00182	CcSEcCtD
Pantoprazole—Alopecia—Docetaxel—head and neck cancer	0.000485	0.00182	CcSEcCtD
Pantoprazole—Dyspnoea—Fluorouracil—head and neck cancer	0.000482	0.0018	CcSEcCtD
Pantoprazole—Mental disorder—Docetaxel—head and neck cancer	0.000481	0.0018	CcSEcCtD
Pantoprazole—Somnolence—Fluorouracil—head and neck cancer	0.000481	0.0018	CcSEcCtD
Pantoprazole—Malnutrition—Docetaxel—head and neck cancer	0.000478	0.00179	CcSEcCtD
Pantoprazole—Vomiting—Hydroxyurea—head and neck cancer	0.000477	0.00179	CcSEcCtD
Pantoprazole—Dyspepsia—Fluorouracil—head and neck cancer	0.000476	0.00178	CcSEcCtD
Pantoprazole—Rash—Hydroxyurea—head and neck cancer	0.000474	0.00177	CcSEcCtD
Pantoprazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000473	0.00665	CbGpPWpGaD
Pantoprazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000473	0.00177	CcSEcCtD
Pantoprazole—Headache—Hydroxyurea—head and neck cancer	0.00047	0.00176	CcSEcCtD
Pantoprazole—Decreased appetite—Fluorouracil—head and neck cancer	0.00047	0.00176	CcSEcCtD
Pantoprazole—Dysgeusia—Docetaxel—head and neck cancer	0.000468	0.00175	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000467	0.00175	CcSEcCtD
Pantoprazole—Back pain—Docetaxel—head and neck cancer	0.000462	0.00173	CcSEcCtD
Pantoprazole—Pain—Fluorouracil—head and neck cancer	0.000462	0.00173	CcSEcCtD
Pantoprazole—Muscle spasms—Docetaxel—head and neck cancer	0.00046	0.00172	CcSEcCtD
Pantoprazole—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000455	0.00639	CbGpPWpGaD
Pantoprazole—Nausea—Hydroxyurea—head and neck cancer	0.000446	0.00167	CcSEcCtD
Pantoprazole—Feeling abnormal—Fluorouracil—head and neck cancer	0.000445	0.00167	CcSEcCtD
Pantoprazole—Anaemia—Docetaxel—head and neck cancer	0.000442	0.00165	CcSEcCtD
Pantoprazole—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000431	0.00605	CbGpPWpGaD
Pantoprazole—Urticaria—Fluorouracil—head and neck cancer	0.000429	0.00161	CcSEcCtD
Pantoprazole—Syncope—Docetaxel—head and neck cancer	0.000429	0.00161	CcSEcCtD
Pantoprazole—Leukopenia—Docetaxel—head and neck cancer	0.000428	0.0016	CcSEcCtD
Pantoprazole—Body temperature increased—Fluorouracil—head and neck cancer	0.000427	0.0016	CcSEcCtD
Pantoprazole—Palpitations—Docetaxel—head and neck cancer	0.000422	0.00158	CcSEcCtD
Pantoprazole—Loss of consciousness—Docetaxel—head and neck cancer	0.00042	0.00157	CcSEcCtD
Pantoprazole—Cough—Docetaxel—head and neck cancer	0.000417	0.00156	CcSEcCtD
Pantoprazole—Convulsion—Docetaxel—head and neck cancer	0.000414	0.00155	CcSEcCtD
Pantoprazole—Hypertension—Docetaxel—head and neck cancer	0.000413	0.00155	CcSEcCtD
Pantoprazole—Myalgia—Docetaxel—head and neck cancer	0.000407	0.00152	CcSEcCtD
Pantoprazole—Chest pain—Docetaxel—head and neck cancer	0.000407	0.00152	CcSEcCtD
Pantoprazole—Arthralgia—Docetaxel—head and neck cancer	0.000407	0.00152	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000404	0.00151	CcSEcCtD
Pantoprazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000398	0.00149	CcSEcCtD
Pantoprazole—Dry mouth—Docetaxel—head and neck cancer	0.000398	0.00149	CcSEcCtD
Pantoprazole—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000396	0.00557	CbGpPWpGaD
Pantoprazole—Confusional state—Docetaxel—head and neck cancer	0.000393	0.00147	CcSEcCtD
Pantoprazole—Anaphylactic shock—Docetaxel—head and neck cancer	0.00039	0.00146	CcSEcCtD
Pantoprazole—Oedema—Docetaxel—head and neck cancer	0.00039	0.00146	CcSEcCtD
Pantoprazole—Infection—Docetaxel—head and neck cancer	0.000388	0.00145	CcSEcCtD
Pantoprazole—Shock—Docetaxel—head and neck cancer	0.000384	0.00144	CcSEcCtD
Pantoprazole—Nervous system disorder—Docetaxel—head and neck cancer	0.000383	0.00143	CcSEcCtD
Pantoprazole—Pruritus—Fluorouracil—head and neck cancer	0.000382	0.00143	CcSEcCtD
Pantoprazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.000382	0.00143	CcSEcCtD
Pantoprazole—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000381	0.00536	CbGpPWpGaD
Pantoprazole—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000381	0.00535	CbGpPWpGaD
Pantoprazole—Tachycardia—Docetaxel—head and neck cancer	0.000381	0.00143	CcSEcCtD
Pantoprazole—Skin disorder—Docetaxel—head and neck cancer	0.000379	0.00142	CcSEcCtD
Pantoprazole—Anorexia—Docetaxel—head and neck cancer	0.000372	0.00139	CcSEcCtD
Pantoprazole—Diarrhoea—Fluorouracil—head and neck cancer	0.00037	0.00138	CcSEcCtD
Pantoprazole—Hypotension—Docetaxel—head and neck cancer	0.000365	0.00137	CcSEcCtD
Pantoprazole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—head and neck cancer	0.000364	0.00512	CbGpPWpGaD
Pantoprazole—Dizziness—Fluorouracil—head and neck cancer	0.000357	0.00134	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000355	0.00133	CcSEcCtD
Pantoprazole—Insomnia—Docetaxel—head and neck cancer	0.000353	0.00132	CcSEcCtD
Pantoprazole—Paraesthesia—Docetaxel—head and neck cancer	0.00035	0.00131	CcSEcCtD
Pantoprazole—Dyspnoea—Docetaxel—head and neck cancer	0.000348	0.0013	CcSEcCtD
Pantoprazole—Somnolence—Docetaxel—head and neck cancer	0.000347	0.0013	CcSEcCtD
Pantoprazole—Vomiting—Fluorouracil—head and neck cancer	0.000344	0.00129	CcSEcCtD
Pantoprazole—Dyspepsia—Docetaxel—head and neck cancer	0.000343	0.00129	CcSEcCtD
Pantoprazole—Rash—Fluorouracil—head and neck cancer	0.000341	0.00128	CcSEcCtD
Pantoprazole—Dermatitis—Fluorouracil—head and neck cancer	0.000341	0.00127	CcSEcCtD
Pantoprazole—Decreased appetite—Docetaxel—head and neck cancer	0.000339	0.00127	CcSEcCtD
Pantoprazole—Headache—Fluorouracil—head and neck cancer	0.000339	0.00127	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000337	0.00126	CcSEcCtD
Pantoprazole—Fatigue—Docetaxel—head and neck cancer	0.000336	0.00126	CcSEcCtD
Pantoprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000336	0.00472	CbGpPWpGaD
Pantoprazole—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000335	0.00471	CbGpPWpGaD
Pantoprazole—Constipation—Docetaxel—head and neck cancer	0.000334	0.00125	CcSEcCtD
Pantoprazole—Pain—Docetaxel—head and neck cancer	0.000334	0.00125	CcSEcCtD
Pantoprazole—Feeling abnormal—Docetaxel—head and neck cancer	0.000322	0.0012	CcSEcCtD
Pantoprazole—Nausea—Fluorouracil—head and neck cancer	0.000321	0.0012	CcSEcCtD
Pantoprazole—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00032	0.00449	CbGpPWpGaD
Pantoprazole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000319	0.00119	CcSEcCtD
Pantoprazole—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000316	0.00445	CbGpPWpGaD
Pantoprazole—Body temperature increased—Docetaxel—head and neck cancer	0.000308	0.00115	CcSEcCtD
Pantoprazole—Abdominal pain—Docetaxel—head and neck cancer	0.000308	0.00115	CcSEcCtD
Pantoprazole—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000291	0.0041	CbGpPWpGaD
Pantoprazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000289	0.00405	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Docetaxel—head and neck cancer	0.000287	0.00108	CcSEcCtD
Pantoprazole—ABCG2—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000282	0.00396	CbGpPWpGaD
Pantoprazole—Asthenia—Docetaxel—head and neck cancer	0.00028	0.00105	CcSEcCtD
Pantoprazole—Pruritus—Docetaxel—head and neck cancer	0.000276	0.00103	CcSEcCtD
Pantoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000273	0.00384	CbGpPWpGaD
Pantoprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00027	0.00379	CbGpPWpGaD
Pantoprazole—Diarrhoea—Docetaxel—head and neck cancer	0.000267	0.000999	CcSEcCtD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000264	0.0037	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000264	0.0037	CbGpPWpGaD
Pantoprazole—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000264	0.0037	CbGpPWpGaD
Pantoprazole—Dizziness—Docetaxel—head and neck cancer	0.000258	0.000966	CcSEcCtD
Pantoprazole—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000252	0.00353	CbGpPWpGaD
Pantoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000249	0.0035	CbGpPWpGaD
Pantoprazole—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000249	0.0035	CbGpPWpGaD
Pantoprazole—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000248	0.00349	CbGpPWpGaD
Pantoprazole—Vomiting—Docetaxel—head and neck cancer	0.000248	0.000929	CcSEcCtD
Pantoprazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000247	0.00346	CbGpPWpGaD
Pantoprazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000246	0.00346	CbGpPWpGaD
Pantoprazole—Rash—Docetaxel—head and neck cancer	0.000246	0.000921	CcSEcCtD
Pantoprazole—Dermatitis—Docetaxel—head and neck cancer	0.000246	0.00092	CcSEcCtD
Pantoprazole—Headache—Docetaxel—head and neck cancer	0.000244	0.000915	CcSEcCtD
Pantoprazole—Nausea—Docetaxel—head and neck cancer	0.000232	0.000868	CcSEcCtD
Pantoprazole—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000229	0.00322	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000227	0.00318	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000226	0.00318	CbGpPWpGaD
Pantoprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000222	0.00312	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000214	0.00301	CbGpPWpGaD
Pantoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000213	0.00299	CbGpPWpGaD
Pantoprazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00021	0.00296	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00021	0.00295	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000206	0.0029	CbGpPWpGaD
Pantoprazole—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000203	0.00286	CbGpPWpGaD
Pantoprazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000202	0.00284	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—UROD—head and neck cancer	0.000202	0.00284	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000196	0.00275	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000193	0.00272	CbGpPWpGaD
Pantoprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000188	0.00264	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000188	0.00264	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—UROD—head and neck cancer	0.000187	0.00263	CbGpPWpGaD
Pantoprazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000173	0.00243	CbGpPWpGaD
Pantoprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000172	0.00241	CbGpPWpGaD
Pantoprazole—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000165	0.00233	CbGpPWpGaD
Pantoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000164	0.00231	CbGpPWpGaD
Pantoprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000162	0.00228	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000157	0.0022	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000157	0.0022	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000156	0.0022	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000151	0.00213	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000149	0.0021	CbGpPWpGaD
Pantoprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000147	0.00206	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000145	0.00204	CbGpPWpGaD
Pantoprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	0.000137	0.00192	CbGpPWpGaD
Pantoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000133	0.00187	CbGpPWpGaD
Pantoprazole—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000124	0.00175	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000123	0.00173	CbGpPWpGaD
Pantoprazole—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000123	0.00172	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—IL2—head and neck cancer	0.000118	0.00166	CbGpPWpGaD
Pantoprazole—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000118	0.00165	CbGpPWpGaD
Pantoprazole—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000116	0.00163	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	0.000116	0.00163	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000113	0.00159	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000113	0.00159	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000113	0.00159	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000112	0.00157	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000111	0.00156	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000111	0.00156	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000111	0.00156	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000107	0.00151	CbGpPWpGaD
Pantoprazole—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000106	0.00149	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—UROD—head and neck cancer	0.000104	0.00146	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—UROD—head and neck cancer	0.000101	0.00142	CbGpPWpGaD
Pantoprazole—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	0.0001	0.00141	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	9.68e-05	0.00136	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	9.55e-05	0.00134	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—UROD—head and neck cancer	9.45e-05	0.00133	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	9.18e-05	0.00129	CbGpPWpGaD
Pantoprazole—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	9.05e-05	0.00127	CbGpPWpGaD
Pantoprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	8.92e-05	0.00125	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.91e-05	0.00125	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.82e-05	0.00124	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—NAT2—head and neck cancer	8.39e-05	0.00118	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—UROD—head and neck cancer	8.07e-05	0.00113	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.04e-05	0.00113	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—NAT2—head and neck cancer	7.77e-05	0.00109	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	7.71e-05	0.00108	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.47e-05	0.00105	CbGpPWpGaD
Pantoprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	7.39e-05	0.00104	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.37e-05	0.00104	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—DPYD—head and neck cancer	7.35e-05	0.00103	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.33e-05	0.00103	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	7.08e-05	0.000995	CbGpPWpGaD
Pantoprazole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	6.98e-05	0.000981	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—YAP1—head and neck cancer	6.98e-05	0.000981	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—DPYD—head and neck cancer	6.81e-05	0.000957	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	6.62e-05	0.00093	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—YAP1—head and neck cancer	6.46e-05	0.000908	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.29e-05	0.000883	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.26e-05	0.00088	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—UROD—head and neck cancer	6.23e-05	0.000875	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	5.68e-05	0.000798	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.48e-05	0.00077	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.24e-05	0.000737	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	4.95e-05	0.000696	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	4.68e-05	0.000658	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.57e-05	0.000643	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.57e-05	0.000642	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.52e-05	0.000635	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.46e-05	0.000626	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.46e-05	0.000626	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NAT2—head and neck cancer	4.3e-05	0.000604	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NAT2—head and neck cancer	4.2e-05	0.00059	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—TYMS—head and neck cancer	4.19e-05	0.000589	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.17e-05	0.000585	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTM1—head and neck cancer	4.14e-05	0.000582	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.12e-05	0.000579	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GPX1—head and neck cancer	3.97e-05	0.000557	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	3.93e-05	0.000552	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NAT2—head and neck cancer	3.92e-05	0.000551	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—TYMS—head and neck cancer	3.88e-05	0.000545	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.87e-05	0.000543	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTM1—head and neck cancer	3.84e-05	0.000539	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—DPYD—head and neck cancer	3.77e-05	0.00053	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3.74e-05	0.000526	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—DPYD—head and neck cancer	3.68e-05	0.000517	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GPX1—head and neck cancer	3.67e-05	0.000516	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP1A1—head and neck cancer	3.64e-05	0.000511	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—YAP1—head and neck cancer	3.58e-05	0.000503	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.56e-05	0.0005	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.52e-05	0.000495	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—YAP1—head and neck cancer	3.49e-05	0.000491	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—DPYD—head and neck cancer	3.44e-05	0.000483	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NAT2—head and neck cancer	3.35e-05	0.000471	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—YAP1—head and neck cancer	3.26e-05	0.000459	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.23e-05	0.000453	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.16e-05	0.000444	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—DPYD—head and neck cancer	2.94e-05	0.000413	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—YAP1—head and neck cancer	2.79e-05	0.000392	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.69e-05	0.000378	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NAT2—head and neck cancer	2.59e-05	0.000363	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.45e-05	0.000345	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.35e-05	0.00033	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS2—head and neck cancer	2.34e-05	0.000328	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—DPYD—head and neck cancer	2.27e-05	0.000319	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS2—head and neck cancer	2.16e-05	0.000304	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—YAP1—head and neck cancer	2.15e-05	0.000302	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—TYMS—head and neck cancer	2.15e-05	0.000302	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.14e-05	0.000301	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.12e-05	0.000299	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—TYMS—head and neck cancer	2.1e-05	0.000295	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.1e-05	0.000294	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTM1—head and neck cancer	2.07e-05	0.000291	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTEN—head and neck cancer	2.04e-05	0.000286	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GPX1—head and neck cancer	2.03e-05	0.000286	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.01e-05	0.000283	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GPX1—head and neck cancer	1.99e-05	0.000279	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.97e-05	0.000276	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—TYMS—head and neck cancer	1.96e-05	0.000275	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.94e-05	0.000272	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTEN—head and neck cancer	1.89e-05	0.000265	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GPX1—head and neck cancer	1.86e-05	0.000261	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.84e-05	0.000258	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.83e-05	0.000257	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—TYMS—head and neck cancer	1.67e-05	0.000235	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.66e-05	0.000233	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.65e-05	0.000233	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GPX1—head and neck cancer	1.59e-05	0.000223	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.57e-05	0.000221	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.51e-05	0.000212	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	1.44e-05	0.000202	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.33e-05	0.000187	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TYMS—head and neck cancer	1.29e-05	0.000182	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.29e-05	0.000181	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.28e-05	0.00018	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GPX1—head and neck cancer	1.22e-05	0.000172	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.21e-05	0.00017	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.2e-05	0.000168	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—head and neck cancer	1.17e-05	0.000165	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS2—head and neck cancer	1.17e-05	0.000164	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.09e-05	0.000153	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—head and neck cancer	1.09e-05	0.000153	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTEN—head and neck cancer	1.04e-05	0.000147	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTEN—head and neck cancer	1.02e-05	0.000143	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTEN—head and neck cancer	9.52e-06	0.000134	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS2—head and neck cancer	9.33e-06	0.000131	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTEN—head and neck cancer	8.14e-06	0.000114	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—head and neck cancer	7.37e-06	0.000104	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.2e-06	0.000101	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—head and neck cancer	7.19e-06	0.000101	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—head and neck cancer	6.72e-06	9.44e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTEN—head and neck cancer	6.28e-06	8.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—head and neck cancer	6.02e-06	8.46e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—head and neck cancer	5.88e-06	8.26e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—head and neck cancer	5.74e-06	8.07e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—head and neck cancer	5.49e-06	7.71e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—head and neck cancer	4.69e-06	6.59e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.43e-06	6.23e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—head and neck cancer	3.62e-06	5.09e-05	CbGpPWpGaD
